Proteros Biostructures GmbH announced that it has entered into a strategic collaboration with Nimbus Discovery, LLC to deliver X-ray protein crystal structures for multiple targets.Under the agreement, Proteros will provide structures from its Gallery Structure list, an ever growing catalogue of rea more
Collaborations
News Collaborations
-
Nimbus Discovery and Proteros enter into multi-target X-ray protein crystallography collaboration
-
Researchers use functional MRI to study small-scale strokes
Two Cornell researchers -- one in Manhattan and the other in Ithaca -- aim to develop the first noninvasive functional MRI imaging technique for studying small-scale strokes in mice, which could eventually be used for clinical research in humans. The research is supported by a Samuel C. and Nancy M more
-
MorphoSys Announces Acquisition of Sloning
MorphoSys AG announced the acquisition of Sloning BioTechnology GmbH. The transaction will make MorphoSys the sole source of Sloning's state-of-the-art Slonomics technology, which improves the assembly and quality of protein libraries. By integrating Slonomics into its existing antibody technology p more
Websites Collaborations
Cytos Biotechnology - Preventing Chronic Diseases– a Vital Investment
News Events Overview Rationale for Immunodrugs™ Strategy Board & Management Industry Collaborations Letter of the CEO History Overview Immunodrug™ Platform Immunodrug™ Manufacturing Scientific Collaborations Scientific Publications Pipeline Clinical Trials Disease Areas Overview Board & Management S more
Davos Life Science: Helping Merge Science with Nature
Home Products & Resources Overview Products R & D Publications Toxicology Studies Collaborations Conference Participation Expert Partner Supplements Food and Beverages Cosmetics Regulatory & Tocotrienol Resources About Davos Profile of Davos Life Science Singapore KLK Group The Team Contact Us Gener more
Facet Biotech - Homepage
About Us Pipeline R&D News & Investors Careers Contact Our perspective… it's what sets us apart The strength of our balance sheet and our strategic collaborations with major biotechnology and pharmaceutical companies provide us with the resources needed to fue more





